Brokerages Set Immunome, Inc. (NASDAQ:IMNM) Target Price at $25.33
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have issued a report on the stock in […]
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have issued a report on the stock in […]
